Skip to main content

Navigation group

Type at least 3 characters
1,321 articles

Articles

Original Research

Published on 24 Mar 2023

Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study

in Intensive Care Medicine and Anesthesiology

  • Giorgia Montrucchio
  • Gabriele Sales
  • Eleonora Balzani
  • Davide Lombardo
  • Alice Giaccone
  • Giulia Cantù
  • Giulia D'Antonio
  • Francesca Rumbolo
  • Silvia Corcione
  • Umberto Simonetti
Effectiveness of mid-regional pro-adrenomedullin, compared to other biomarkers (including lymphocyte subpopulations and immunoglobulins), as a prognostic biomarker in COVID-19 critically ill patients: New evidence from a 15-month observational prospective study
Frontiers in Medicine
doi 10.3389/fmed.2023.1122367
  • 3,735 views
  • 7 citations